In 1997 Dr. Emmanuelle M. Voisin Lestringant created Voisin Consulting Life Sciences to support biomedical companies with fully integrated drug development programs. Her expertise includes the design and implementation of preclinical and clinical development plans and harmonized regulatory strategies between Europe and the USA.
Prior to VCLS Emmanuelle was General Manager of Quintiles in France and Spain. She established the French operation in 1992, ensured growth then successfully began operations in Italy and on the Iberian Peninsula. The scope of her functions ranged from General Management (Human Resources, finance, administration) to management of clinical operations, regulatory consulting, project management and business development. She participated in a number of due diligence projects as well as negotiations for acquisitions in France and the UK.
Previously, Emmanuelle started and managed the R&D operations of Laboratoires Besins Iscovesco, USA where she focused on the quality, nonclinical and clinical aspects of global drug development plans. She was a Reviewing Pharmacologist and Toxicologist with the US FDA CDER Division of Antiviral Drug Products in charge of applications for new AIDS therapies, and, before, a Nonclinical Coordinator at Laboratoires Servier in France.
A post-doctorate position at the National Institute of Mental Health (NIMH) was held after her Ph.D. thesis in Pharmacology, from the Institut Gustave Roussy (Oncology), Villejuif, France in collaboration with CNRS and INSERM research units. Emmanuelle is a member of several professional associations including RAPS and DIA, and is actively involved in EuropaBio.
